Research ExplorerPublications[New aspects of HPV-positive head and neck cancer. Highlight...

[New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress].

Standard

[New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress]. / Kofler, Barbara; Uecker, Florian C.; Münscher, Adrian; Knecht, Rainald.

In: HNO, Vol. 60, No. 5, 5, 2012, p. 404-407.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Kofler, B, Uecker, FC, Münscher, A & Knecht, R 2012, '[New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress].', HNO, vol. 60, no. 5, 5, pp. 404-407. <http://www.ncbi.nlm.nih.gov/pubmed/22570004?dopt=Citation>

APA

Kofler, B., Uecker, F. C., Münscher, A., & Knecht, R. (2012). [New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress]. HNO, 60(5), 404-407. [5]. http://www.ncbi.nlm.nih.gov/pubmed/22570004?dopt=Citation

Vancouver

Kofler B, Uecker FC, Münscher A, Knecht R. [New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress]. HNO. 2012;60(5):404-407. 5.

Bibtex

@article{87a89f6213a9454ba89f6e62faa78259,
title = "[New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress].",
abstract = "HPV-positive head and neck carcinoma is significantly different than tobacco- and alcohol-induced cancer. Between 30% and 50% of oropharyngeal cancers are associated with human papillomavirus (HPV). Studies still show an increasing incidence. HPV-positive head and neck cancer patients have a better prognosis due to a better response to therapy. Especially patients with gene overexpression of immunological proteins in the antigen presentation are suggested to benefit from radiotherapy. A current retrospective study shows better outcomes for patients treated with radiotherapy in combination with biological targets compared to radiochemotherapy.",
keywords = "Humans, Papillomaviridae/*isolation & purification, Evidence-Based Medicine/*trends, Chemoradiotherapy/*trends, Head and Neck Neoplasms/*therapy/*virology, Molecular Targeted Therapy/*trends, Humans, Papillomaviridae/*isolation & purification, Evidence-Based Medicine/*trends, Chemoradiotherapy/*trends, Head and Neck Neoplasms/*therapy/*virology, Molecular Targeted Therapy/*trends",
author = "Barbara Kofler and Uecker, {Florian C.} and Adrian M{\"u}nscher and Rainald Knecht",
year = "2012",
language = "Deutsch",
volume = "60",
pages = "404--407",
journal = "HNO",
issn = "0017-6192",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - [New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress].

AU - Kofler, Barbara

AU - Uecker, Florian C.

AU - Münscher, Adrian

AU - Knecht, Rainald

PY - 2012

Y1 - 2012

N2 - HPV-positive head and neck carcinoma is significantly different than tobacco- and alcohol-induced cancer. Between 30% and 50% of oropharyngeal cancers are associated with human papillomavirus (HPV). Studies still show an increasing incidence. HPV-positive head and neck cancer patients have a better prognosis due to a better response to therapy. Especially patients with gene overexpression of immunological proteins in the antigen presentation are suggested to benefit from radiotherapy. A current retrospective study shows better outcomes for patients treated with radiotherapy in combination with biological targets compared to radiochemotherapy.

AB - HPV-positive head and neck carcinoma is significantly different than tobacco- and alcohol-induced cancer. Between 30% and 50% of oropharyngeal cancers are associated with human papillomavirus (HPV). Studies still show an increasing incidence. HPV-positive head and neck cancer patients have a better prognosis due to a better response to therapy. Especially patients with gene overexpression of immunological proteins in the antigen presentation are suggested to benefit from radiotherapy. A current retrospective study shows better outcomes for patients treated with radiotherapy in combination with biological targets compared to radiochemotherapy.

KW - Humans

KW - Papillomaviridae/isolation & purification

KW - Evidence-Based Medicine/trends

KW - Chemoradiotherapy/trends

KW - Head and Neck Neoplasms/therapy/virology

KW - Molecular Targeted Therapy/trends

KW - Humans

KW - Papillomaviridae/isolation & purification

KW - Evidence-Based Medicine/trends

KW - Chemoradiotherapy/trends

KW - Head and Neck Neoplasms/therapy/virology

KW - Molecular Targeted Therapy/trends

M3 - SCORING: Zeitschriftenaufsatz

VL - 60

SP - 404

EP - 407

JO - HNO

JF - HNO

SN - 0017-6192

IS - 5

M1 - 5

ER -